Zai Lab aims to raise $200M; Kronos Bio to seek ‘strategic’ options

Plus, news about Allogene, Telix, Cullgen, Pulmatrix, Gilead, Innocoll, Durect and Sensei:

Zai Lab’s $200M offering: The Shanghai-based drugmaker is

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Embracing SDOH Data Monitoring for Transformative Healthcare

Christine Lee, Head of Health Partnerships at AnalyticsIQ Understanding the multifaceted dimensions of patient wellness goes beyond the medical symptoms presented in a clinical setting.

November 28, 2023

Semaglutide shows significant weight loss and health benefits in four-year obesity study

A study in Nature Medicine evaluated the effects of semaglutide on weight and anthropometric outcomes in adults with obesity but without diabetes, finding significant weight

May 15, 2024

Advancing neurotoxicity research with INTEGRA pipettes

INTEGRA Biosciences has awarded 31 EVOLVE manual pipettes, GRIPTIPS® pipette tips worth US $1000, and lab accessories to the bioanalytical company DNTOX as part of its recent

October 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.